PGEN:NASDAQ
Precigen Inc
7,36 $
arrow_downward
-1,67%(-0,12) 1D
7,26 $
arrow_downward
-1,29% (-0,095)todayPre-market
Closed: 14 қаз., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
7,48 $
High
7,70 $
Low
7,33 $
Mkt. cap
2,63 млрд
Avg. vol.
4,68 млн
Volume
629,00
52-wk high
8,98 $
52-wk low
3,04 $
EPS
-1,10 $
Beta
0,92
Shares outstanding
358,04 млн
No. of employees
160
Open
7,48 $
High
7,70 $
Low
7,33 $
Mkt. cap
2,63 млрд
Avg. vol.
4,68 млн
Volume
629,00
52-wk high
8,98 $
52-wk low
3,04 $
EPS
-1,10 $
Beta
0,92
Shares outstanding
358,04 млн
No. of employees
160
News stories
From web sources and news partners
Yahoo Finance
·
2 күн бұрын
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc